Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹4082 Cr | ₹1325 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 31 Dec 2004 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | 32% | 26.49% |
| Expense Ratio | 1.94 | 2.14 |
| Manager | Pradeep Kesavan | Meeta Shetty |
| ISIN Code | INF200K01446 | INF277K016A9 |
| Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -1.61% | -0.82% |
| 6 Month | -0.56% | 1.29% |
| 1 Year | -1.72% | -1.03% |
| 3 Year | 23.41% | 21.78% |
| 5 Year | 17.27% | 15.94% |
SIP Return Analysis
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | -0.02% | 0.51% |
| 1 Year | 4.24% | 6.3% |
| 3 Year | 19.42% | 17.98% |
| 5 Year | 18.98% | 17.13% |
Rolling Lumpsum Returns
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 15.37% | 8.63% |
| 3 Year | 18% | 18.84% |
| 5 Year | 13.25% | 15.73% |
Risk Management
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.02% | 16.04% |
| Sharp | 1.2% | 0.91% |
| Beta | 0.8% | 0.98% |
| Alpha | 4.66% | -1.01% |
Fund Managers
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Pradeep Kesavan | Meeta Shetty |
| Total AUM | ₹434274 Cr | ₹17847 Cr |
| Funds Managed | 43 | 5 |
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 13.88 | 3.86 |
| Mid Cap | 26.99 | 38.84 |
| Small Cap | 32.79 | 34.36 |
| Large Cap | 26.35 | 22.93 |
Sector Allocation
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 3.93 | 1.5 |
| Basic Materials | 6.39 | 2.17 |
| Healthcare | 89.67 | 96.33 |
| Financial Services | - | 0 |
Top Comparisons
Bandhan Money Market Fund - Regular Plan - Growth
3Y Returns7.05%
HSBC Money Market Fund - Regular Growth
3Y Returns7.23%
Nippon India Index Fund - Nifty 50 Plan - Growth Plan - Growth Option
3Y Returns12.47%
Motilal Oswal Nifty Midcap 150 Index Fund - Regular Plan
3Y Returns21.11%
Nippon India Quant Fund -Growth Plan - Growth Option
3Y Returns18.64%
Quant ESG Integration Strategy Fund Regular - Growth
3Y Returns13.8%
Bajaj Finserv Flexi Cap Fund Regular - Growth
3Y Returns0%
Canara Robeco Flexicap Fund - Regular Plan - Growth Option
3Y Returns14.52%